These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 8622219)
21. Human acyl-CoA:cholesterol acyltransferase (ACAT) and its potential as a target for pharmaceutical intervention against atherosclerosis. Chang C; Dong R; Miyazaki A; Sakashita N; Zhang Y; Liu J; Guo M; Li BL; Chang TY Acta Biochim Biophys Sin (Shanghai); 2006 Mar; 38(3):151-6. PubMed ID: 16518538 [TBL] [Abstract][Full Text] [Related]
22. What kinds of studies should be required to probe efficacy and safety of drugs in special populations? LaRosa JC; Sneider GB; Boyle C Am J Cardiol; 1998 Apr; 81(8A):84F-87F. PubMed ID: 9604921 [No Abstract] [Full Text] [Related]
23. FDA approves kallikrein inhibitor to treat hereditary angioedema. Thompson CA Am J Health Syst Pharm; 2010 Jan; 67(2):93. PubMed ID: 20065259 [No Abstract] [Full Text] [Related]
24. How well tolerated are lipid-lowering drugs? Tomlinson B; Chan P; Lan W Drugs Aging; 2001; 18(9):665-83. PubMed ID: 11599634 [TBL] [Abstract][Full Text] [Related]
25. An overview of patented small molecule stearoyl coenzyme-A desaturase inhibitors (2009 - 2013). Powell DA Expert Opin Ther Pat; 2014 Feb; 24(2):155-75. PubMed ID: 24251719 [TBL] [Abstract][Full Text] [Related]
26. Fish oil supplements. Med Lett Drugs Ther; 2012 Oct; 54(1401):83-4. PubMed ID: 23059421 [No Abstract] [Full Text] [Related]
27. Lipid-metabolizing enzymes, CoASH and long-chain acyl-CoA in rat liver after treatment with tiadenol, nicotinic acid and niadenate. Bakke OM; Berge RK Biochem Pharmacol; 1982 Dec; 31(23):3930-3. PubMed ID: 7159471 [No Abstract] [Full Text] [Related]
29. Lipid-lowering agents that cause drug-induced hepatotoxicity. Bhardwaj SS; Chalasani N Clin Liver Dis; 2007 Aug; 11(3):597-613, vii. PubMed ID: 17723922 [TBL] [Abstract][Full Text] [Related]
30. Preventing prostate cancer: new analyses put finasteride back on the map. Vastag B J Natl Cancer Inst; 2008 Aug; 100(16):1132-3. PubMed ID: 18695128 [No Abstract] [Full Text] [Related]
31. Drug approval triggers debate on future direction for cancer treatments. Frantz S Nat Rev Drug Discov; 2006 Feb; 5(2):91. PubMed ID: 16521324 [No Abstract] [Full Text] [Related]
32. Blood cholesterol measurement in young adults. Tobert JA JAMA; 1993 Aug; 270(8):936; author reply 937-8. PubMed ID: 8345639 [No Abstract] [Full Text] [Related]
33. Was the flu drug zanamivir a breakthrough or money for old rope? Moynihan R BMJ; 2014 Jun; 348():g3611. PubMed ID: 24891329 [No Abstract] [Full Text] [Related]
34. Persistence of use of lipid-lowering medications: a cross-national study. Avorn J; Monette J; Lacour A; Bohn RL; Monane M; Mogun H; LeLorier J JAMA; 1998 May; 279(18):1458-62. PubMed ID: 9600480 [TBL] [Abstract][Full Text] [Related]
35. Multiple-dose pharmacokinetics, pharmacodynamics, and safety of atorvastatin, an inhibitor of HMG-CoA reductase, in healthy subjects. Cilla DD; Whitfield LR; Gibson DM; Sedman AJ; Posvar EL Clin Pharmacol Ther; 1996 Dec; 60(6):687-95. PubMed ID: 8988072 [TBL] [Abstract][Full Text] [Related]